Latalux

Latanoprost, the active ingredient in Latalux, is a prostaglandin analog presented as eye drops for ocular use. It lowers intra‑ocular pressure and is indicated for the management of open‑angle glaucoma and ocular hypertension in adult patients. By enhancing uveoscleral outflow of aqueous humor, the medication helps preserve visual function and prevent disease progression.

GNH USA supplies Latalux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Latalux (latanoprost) is employed in ocular conditions where lowering intra‑ocular pressure is essential to protect the optic nerve, maintain visual field, and prevent disease progression. - Open‑angle glaucoma: decreases intra‑ocular pressure by increasing aqueous humor outflow, thereby slowing progression of optic nerve damage and preserving visual field. - Ocular hypertension: lowers elevated eye pressure in patients without established glaucoma, reducing the risk of future glaucomatous damage.

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and reversible. Common Side Effects: - Eye redness: transient conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual change in eye color. - Eye irritation: foreign body sensation or mild discomfort. Serious or Rare Side Effects: - Uveitis: inflammation of the uveal tract. - Macular edema: swelling of the central retina. - Severe allergic reaction: contact dermatitis or swelling.

When prescribing Latalux, clinicians should consider several safety measures to minimize risk and ensure optimal therapeutic outcome. - Baseline intra‑ocular pressure assessment: measure IOP before initiating therapy. - Monitor iris color changes: observe for gradual darkening during treatment. - Avoid use in active ocular inflammation: contraindicated in uveitis or infection. - Caution in patients with herpetic eye disease: may trigger reactivation. - Do not combine with other prostaglandin analog eye drops: increased risk of side effects. - Store at room temperature: keep in original container, protect from light and moisture.

Latalux can interact with other ophthalmic agents, affecting efficacy or safety. Major Interactions (Avoid): - Other prostaglandin analog eye drops: additive ocular side effects and unpredictable pressure changes. - Systemic carbonic anhydrase inhibitors: may potentiate intra‑ocular pressure reduction leading to hypotony. Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: monitor intra‑ocular pressure for additive effect. - Anticholinergic eye drops: observe for changes in ocular surface tolerance. - Topical corticosteroids: watch for increased risk of cataract formation. - Non‑steroidal anti‑inflammatory eye drops: may reduce prostaglandin efficacy.